Page 46 |
Save page Remove page | Previous | 46 of 144 | Next |
|
small (250x250 max)
medium (500x500 max)
Large (1000x1000 max)
Extra Large
large ( > 500x500)
Full Resolution
All (PDF)
|
This page
All
|
blotted with anti-phospho-ERK1/2 (P-ERK1/2) and anti-ERK1/2, respectively. 10 mM and 25 mM of nicotinamide decreased phosphorylated ERK1/2 (Fig. 8 B). The effect of sirtinol was dose-dependent as 30 μM of sirtinol reduced the ratio of P-ERK/ERK by 45% while 60 μM of sirtinol reduced the ratio of P-ERK/ERK by 68% (Fig. 8 C, D) (P <0.05, control vs. sirtinol 30 μM; P <0.01, control vs. sirtinol 60 μM; n=4, One-way ANOVA, Turkey's test).
Figure 9. Inhibition of SIRT1 deacetylase decreases ERK1/2 activation in cultured neurons and in vivo
(A) 7 DIV cortical neurons were transfected with either U6Pro-SIRT1-siRNA + GFP or dominant-negative GFP-SirT2 (SirT2DN) and 48 hrs later were immunostained with anti-phospho-ERK1/2. (B) Quantification of immunodensity from 12 transfected and 12 nearby non-transfected cells for SIRT1 siRNA and SirT2DN, respectively (P<0.05, control vs. SIRT1 siRNA, n=12). (C, D) Representative blots (C) and quantification (D) showing the effect of SIRT1 deacetylase on ERK1/2 signaling in the hippocampus of mice (*P<0.05, SIRT1+/+ vs. SIRT1-/-, n=6).
36
Object Description
| Title | Roles of SIRT1 in neuronal oxidative damage and brain function |
| Author | Li, Ying |
| Author email | lying@usc.edu; yingraceli@yahoo.com |
| Degree | Doctor of Philosophy |
| Document type | Dissertation |
| Degree program | Neuroscience |
| School | College of Letters, Arts and Sciences |
| Date defended/completed | 2008-09-12 |
| Date submitted | 2008 |
| Restricted until | Unrestricted |
| Date published | 2008-10-30 |
| Advisor (committee chair) | Longo, Valter D. |
| Advisor (committee member) |
Baudry, Michel Pike, Christian J. Madigan, Stephen A. |
| Abstract | Aging is a common phenomenon of multiple organisms. In humans aging is frequently accompanied by cognitive decline and occurrence of neurodegenerative diseases which reduce the quality of life and impose financial stress on society. Delaying the aging process, extending life span and decreasing the occurrence of age-related brain function deficit have always been aspirations of human kind. Extensive research has advanced our understanding of the mechanisms underlying aging, among which is the ability of calorie restriction to increase longevity, and the pivotal regulatory roles of insulin/IGF-1 signaling pathway. Some recent studies identified silent information regulator 2 (Sir2; SIRT1 is the mammalian homolog) as a key mediator of the beneficial effects of calorie restriction and this prompted development of SIRT1 activators for human consumption to delay aging and accompanying cognitive decline. However, our laboratory previously showed in yeast that Sir2 can increase stress sensitivity and limit life span extension under certain conditions, calling for more detailed characterization of SIRT1. In the research described in this dissertation I extended this study to the mammalian system and focused on the role of SIRT1 on the health of neurons and brain functions, especially learning and memory.; This dissertation consists of three chapters. In chapter 1 I briefly review some recent progress on aging, oxidative stress, insulin/IGF-1 signaling pathway and learning and memory with emphasis on the involvement of SIRT1 in these processes. In chapter 2 I focused on the role of SIRT1 in oxidative stress in neurons and its mechanisms. I found that SIRT1 inhibition increased resistance to oxidative damage and this effect is partially mediated by a reduction in IGF-I/IRS-2/Ras/ERK1/2 signaling. In chapter 3 I studied the functions of SIRT1 in learning and memory. The experiments showed that deletion of SIRT1 impairs a certain form of synaptic plasticity and reduce performance in several different learning and memory tasks while overexpressing SIRT1 did not substantially affect learning and memory.; Together, my studies reveal that SIRT1 exacerbates neuronal oxidative damage but is essential in learning and memory, indicating that SIRT1 plays multiple roles in aging and brain functions and that caution should be exercised in designing anti-aging or therapeutic approaches that involve targeting SIRT1. |
| Keyword | SIRT1; neurons; brain; oxidative damage; learning and memory |
| Language | English |
| Part of collection | University of Southern California dissertations and theses |
| Publisher (of the original version) | University of Southern California |
| Place of publication (of the original version) | Los Angeles, California |
| Publisher (of the digital version) | University of Southern California. Libraries |
| Provenance | Electronically uploaded by the author |
| Type | texts |
| Legacy record ID | usctheses-m1723 |
| Contributing entity | University of Southern California |
| Rights | Li, Ying |
| Repository name | Libraries, University of Southern California |
| Repository address | Los Angeles, California |
| Repository email | cisadmin@lib.usc.edu |
| Filename | etd-LI-2405 |
| Archival file | uscthesesreloadpub_Volume44/etd-LI-2405.pdf |
Description
| Title | Page 46 |
| Contributing entity | University of Southern California |
| Repository email | cisadmin@lib.usc.edu |
| Full text | blotted with anti-phospho-ERK1/2 (P-ERK1/2) and anti-ERK1/2, respectively. 10 mM and 25 mM of nicotinamide decreased phosphorylated ERK1/2 (Fig. 8 B). The effect of sirtinol was dose-dependent as 30 μM of sirtinol reduced the ratio of P-ERK/ERK by 45% while 60 μM of sirtinol reduced the ratio of P-ERK/ERK by 68% (Fig. 8 C, D) (P <0.05, control vs. sirtinol 30 μM; P <0.01, control vs. sirtinol 60 μM; n=4, One-way ANOVA, Turkey's test). Figure 9. Inhibition of SIRT1 deacetylase decreases ERK1/2 activation in cultured neurons and in vivo (A) 7 DIV cortical neurons were transfected with either U6Pro-SIRT1-siRNA + GFP or dominant-negative GFP-SirT2 (SirT2DN) and 48 hrs later were immunostained with anti-phospho-ERK1/2. (B) Quantification of immunodensity from 12 transfected and 12 nearby non-transfected cells for SIRT1 siRNA and SirT2DN, respectively (P<0.05, control vs. SIRT1 siRNA, n=12). (C, D) Representative blots (C) and quantification (D) showing the effect of SIRT1 deacetylase on ERK1/2 signaling in the hippocampus of mice (*P<0.05, SIRT1+/+ vs. SIRT1-/-, n=6). 36 |
